[go: up one dir, main page]

CL2007001713A1 - Oral pharmaceutical composition in the form of an aqueous suspension comprising particles of the benzimidazole carbamate anthelmintic with a 90% average size less than 450 nm and a polysorbate surfactant; method for its preparation; method of preparing a medicine; and use to control parasitic infections in animals. - Google Patents

Oral pharmaceutical composition in the form of an aqueous suspension comprising particles of the benzimidazole carbamate anthelmintic with a 90% average size less than 450 nm and a polysorbate surfactant; method for its preparation; method of preparing a medicine; and use to control parasitic infections in animals.

Info

Publication number
CL2007001713A1
CL2007001713A1 CL2007001713A CL2007001713A CL2007001713A1 CL 2007001713 A1 CL2007001713 A1 CL 2007001713A1 CL 2007001713 A CL2007001713 A CL 2007001713A CL 2007001713 A CL2007001713 A CL 2007001713A CL 2007001713 A1 CL2007001713 A1 CL 2007001713A1
Authority
CL
Chile
Prior art keywords
pharmaceutical composition
particles
aqueous suspension
anthelmintic
animals
Prior art date
Application number
CL2007001713A
Other languages
Spanish (es)
Inventor
Elisabeth Benedicte Daniele Deschamps
Mark Allan
Carsten Schmidt
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37546337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007001713(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CL2007001713A1 publication Critical patent/CL2007001713A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición farmacéutica que comprende una suspensión acuosa que comprende partículas de carbamato de bencimidazol con un tamaño de partícula menor que 450 nm y un surfactante tipo tween; y su uso como antiparasitario.Pharmaceutical composition comprising an aqueous suspension comprising benzimidazole carbamate particles with a particle size less than 450 nm and a tween type surfactant; and its use as an antiparasitic.

CL2007001713A 2006-06-14 2007-06-12 Oral pharmaceutical composition in the form of an aqueous suspension comprising particles of the benzimidazole carbamate anthelmintic with a 90% average size less than 450 nm and a polysorbate surfactant; method for its preparation; method of preparing a medicine; and use to control parasitic infections in animals. CL2007001713A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81392806P 2006-06-14 2006-06-14
EP06115495 2006-06-14

Publications (1)

Publication Number Publication Date
CL2007001713A1 true CL2007001713A1 (en) 2008-01-18

Family

ID=37546337

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2007001713A CL2007001713A1 (en) 2006-06-14 2007-06-12 Oral pharmaceutical composition in the form of an aqueous suspension comprising particles of the benzimidazole carbamate anthelmintic with a 90% average size less than 450 nm and a polysorbate surfactant; method for its preparation; method of preparing a medicine; and use to control parasitic infections in animals.

Country Status (9)

Country Link
CN (1) CN101466373B (en)
BR (1) BRPI0712734B1 (en)
CL (1) CL2007001713A1 (en)
DK (1) DK2037914T3 (en)
ES (1) ES2440485T3 (en)
MY (1) MY153292A (en)
RU (1) RU2445089C2 (en)
TW (1) TW200815001A (en)
UA (1) UA93403C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107041373A (en) * 2017-05-09 2017-08-15 李洪军 A kind of crops long-acting fungicide
CN110693830B (en) * 2019-10-10 2021-09-17 华中农业大学 Veterinary oxfendazole nano suspension and preparation method thereof
CN118986876A (en) * 2024-08-09 2024-11-22 山东德州神牛药业有限公司 Iodoethersalamine nanosuspension and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093497A3 (en) * 1982-04-30 1985-03-20 Smith Kline & French Laboratories Limited Anthelmintic treatment
AU698431B2 (en) * 1993-12-13 1998-10-29 Michael Hilary Burke Anthelmintic composition containing rafoxanide and fenbendazole
IES950907A2 (en) * 1995-12-01 1996-02-21 Chanelle Chemicals Ltd "A process"

Also Published As

Publication number Publication date
ES2440485T3 (en) 2014-01-29
RU2009100919A (en) 2010-07-20
UA93403C2 (en) 2011-02-10
DK2037914T3 (en) 2014-01-20
BRPI0712734A2 (en) 2012-10-02
MY153292A (en) 2015-01-29
CN101466373A (en) 2009-06-24
BRPI0712734B1 (en) 2020-06-16
RU2445089C2 (en) 2012-03-20
CN101466373B (en) 2012-11-21
TW200815001A (en) 2008-04-01

Similar Documents

Publication Publication Date Title
AR115939A2 (en) COMPOSITION CONTAINING ULTRA-MICRONIZED PALMITOYL-ETHANOLAMIDE
CL2019000209A1 (en) Novel orally administrable formulation.
ES2721898T3 (en) Stable formulations to lyophilize therapeutic particles
CL2008001984A1 (en) Anti-cd20 antibody formulation; and its use to treat diseases involving cd20-expressing cells in a mammal.
AR080662A1 (en) SOLID ORAL DOSE FORM WITH NANOPARTICLE CONTENT AND FORMULATION PROCESS OF THE SAME USING FISH GELATINE
HK1208162A1 (en) Pharmaceutical nanoparticles showing improved mucosal transport
NI201600093A (en) COMPOSITE FORMULATION FOR ORAL ADMINISTRATION INCLUDING EZETIMIBE AND ROSUVASTATIN
GT201400069A (en) PHARMACEUTICAL COMPOSITIONS
ECSP11011289A (en) GALENIC FORMULATIONS OF ORGANIC COMPOUNDS
UY37326A (en) SOLID DISPERSIONS EXTRUDED BY FUSION CONTAINING AN APOPTOSIS INDUCTIVE AGENT
AR063940A1 (en) FORMULATIONS OF NANOPARTICULATED POSACONAZOL
HK1208161A1 (en) Pharmaceutical nanoparticles showing improved mucosal transport
JP2011525477A5 (en)
MX2010003642A (en) Vaccine nanotechnology.
AR077225A1 (en) INJECTABLE FORMULATIONS CONTAINING ASENAPINE AND TREATMENT METHOD THAT USES THEM
AR082688A1 (en) USE OF BINDERS TO PREPARE STORAGE FORMULATIONS TO STORAGE
NZ595987A (en) A novel formulation of diclofenac
AR061351A1 (en) BENCIMIDAZOL CARBAMATE COMPOSITION
AR084581A1 (en) ORAL CARE WATERY COMPOSITIONS
CL2012001836A1 (en) Pyrazole compounds, crth2 antagonist; pharmaceutical composition; use in the treatment of inflammatory, infectious, immunoregulatory disorders, respiratory diseases, gastrointestinal or ailments, among others.
CL2017001836A1 (en) A fertilizer composition and the method of its use.
AR075180A1 (en) SOLID ORAL FORMULATIONS OF A PYRIDOID-PYRIMIDINONE
AR085527A1 (en) A PHARMACEUTICAL COMPOSITION TO TREAT AN ORAL CAVITY DISEASE THAT REBAMIPIDA INCLUDES
UY29395A1 (en) FORMULATION OF MEDICINES CONTAINING VARDENAFILO.
MX2022009231A (en) DRY POWDER INHALER AND METHOD OF USE.